General AML

Based on your analysis, should current AML risk stratification be revised?

L: English

During the 61st American Society of Hematology (ASH) meeting in Orlando, US, the AML Global Portal was delighted to speak to Ilaria Iacobucci, St. Jude Children's Research Hospital, Memphis, US. We asked: Based on your analysis, should current acute myeloid leukemia risk stratification be revised?

Ilaria Iacobucci explains that it is possible to use additional genomic features to better stratify patients. These genomic features can be also used for guiding new therapeutic approaches for high-risk AML patients.